Tianjin Pharmaceutical Group Co., Ltd. Sustainability Profile
Tianjin Pharmaceutical Group Co., Ltd., commonly referred to as Tianjin Pharma, is a leading player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and biopharmaceuticals. With a strong presence in both domestic and international markets, Tianjin Pharma is renowned for its commitment to quality and innovation. The company’s core offerings are distinguished by their adherence to stringent regulatory standards and advanced manufacturing processes. Over the years, Tianjin Pharmaceutical Group has achieved notable milestones, solidifying its position as a trusted name in healthcare solutions.
DitchCarbon Score
How does Tianjin Pharmaceutical Group Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianjin Pharmaceutical Group Co., Ltd.'s score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianjin Pharmaceutical Group Co., Ltd.'s reported carbon emissions
In 2024, Tianjin Pharmaceutical Group Co., Ltd. reported total carbon emissions of approximately 28,918,010 kg CO2e, which includes 4,228,380 kg CO2e from Scope 1 emissions and 24,689,630 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Despite the significant emissions figures, there are currently no specific reduction targets or climate pledges outlined in their sustainability initiatives. The emissions data is cascaded from the parent company, Tianjin Pharmaceutical Group Co., Ltd., indicating a corporate family relationship that influences their reporting. Tianjin Pharmaceutical Group's commitment to addressing climate change is evident through their transparency in emissions reporting, although further details on reduction strategies or targets are not available at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 4,228,380 |
| Scope 2 | 24,689,630 |
| Scope 3 | - |
How Carbon Intensive is Tianjin Pharmaceutical Group Co., Ltd.'s Industry?
How Carbon Intensive is Tianjin Pharmaceutical Group Co., Ltd.'s Location?
Tianjin Pharmaceutical Group Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tianjin Pharmaceutical Group Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
